HSPA5/Dna K May Be a Useful Target for Human Disease Therapies

von Booth, Laurence, Roberts, Jane L., Dent, Paul
Veröffentlicht in DNA Cell Biol (2015)

Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species

von Roberts, Jane L., Poklepovic, Andrew, Booth, Laurence
Veröffentlicht in Oncotarget (2017)

The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib

von Booth, Laurence A., Roberts, Jane L., Dent, Paul
Veröffentlicht in Semin Cancer Biol (2019)

PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Oncotarget (2017)

[pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Cancer Biol Ther (2017)

NEDD4 over-expression regulates the afatinib resistant phenotype of NSCLC cells

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Oncol Signal (2017)

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Front Oncol (2019)

Rationally Repurposing Ruxolitinib (Jakafi(®)) as a Solid Tumor Therapeutic

von Tavallai, Mehrad, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Front Oncol (2016)

PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Gordon, Sarah, Dent, Paul
Veröffentlicht in Oncotarget (2016)

HDAC inhibitors enhance the immunotherapy response of melanoma cells

von Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Kirkwood, John, Dent, Paul
Veröffentlicht in Oncotarget (2017)

Valproate augments Niraparib killing of tumor cells

von Booth, Laurence, Roberts, Jane L., Rais, Rumeesa, Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Cancer Biol Ther (2018)

Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells

von Booth, Laurence, Roberts, Jane L., Kirkwood, John, Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Adv Cancer Res (2018)

Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition

von Booth, Laurence, Roberts, Jane L., Spiegel, Sarah, Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Cancer Biol Ther (2018)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

von Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Veröffentlicht in Front Oncol (2020)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells

von Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Hancock, John F.
Veröffentlicht in Front Oncol (2020)

Regulation of OSU-03012 toxicity by ER stress proteins and ER stress inducing drugs

von Booth, Laurence, Roberts, Jane L., Cruickshanks, Nichola, Grant, Steven, Poklepovic, Andrew, Dent, Paul
Veröffentlicht 2014

Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43

von Dent, Paul, Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Cridebring, Derek, Reiman, Eric M.
Veröffentlicht in Aging (Albany NY) (2021)

Regulation of dimethyl-fumarate toxicity by proteasome inhibitors

von Booth, Laurence, Cruickshanks, Nichola, Tavallai, Seyedmehrad, Roberts, Jane L, Peery, Matthew, Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Cancer Biol Ther (2014)

Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS

von Tavallai, Mehrad, Booth, Laurence, Roberts, Jane L., McGuire, William P., Poklepovic, Andrew, Dent, Paul
Veröffentlicht in Oncotarget (2016)

Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo

von Booth, Laurence, Albers, Thomas, Roberts, Jane L., Tavallai, Mehrad, Poklepovic, Andrew, Lebedyeva, Iryna O., Dent, Paul
Veröffentlicht in Oncotarget (2016)